Publications
Below you can find a list of our published research.
Below you can find a list of our published research.
6177 results
Cited 92 times since 1996 (3.2 per year) source: EuropePMC
Circulation, Volume 94, Issue 7, 1 1 1996, Pages 1503-1505 Reduction of transient myocardial ischemia with pravastatin in addition to the conventional treatment in patients with angina pectoris. REGRESS Study Group. van Boven AJ, Jukema JW, Zwinderman AH, Crijns HJ, Lie KI, Bruschke AV
Background: Lipid-lowering therapy reduces cardiac morbidity and mortality. Less is known about its potential anti-ischemic effect. Methods and results: In a 2-year prospective randomized placebo-controlled study, the effect of pravastatin 40 mg on transient myocardial ischemia was assessed. Forty-eight-hour ambulatory ECGs with continuous ST-segment analysis were performed in 768 male patients with stable angina pectoris, documented coronary artery disease, and serum cholesterol between 4 and 8... Abstract
Cited 60 times since 1996 (2.1 per year) source: EuropePMC
Circulation, Volume 94, Issue 8, 1 1 1996, Pages 1913-1918 The Asp9 Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. REGRESS Study Group, Interuniversity Cardiology Institute, Utrecht, The Netherlands. Regression Growth Evaluation Statin Study. Jukema JW, van Boven AJ, Groenemeijer B, Zwinderman AH, Reiber JH, Bruschke AV, Henneman JA, Molhoek GP, Bruin T, Jansen H, Gagné E, Hayden MR, Kastelein JJ
Background: Many patients suffering from premature coronary artery disease report a family history for such events. A mutation in a particular gene, which confers susceptibility for atherosclerosis, will be found more frequently in individuals suffering from coronary atherosclerosis than in the general population. We have recently reported the identification of an Asp9 Asn substitution in the lipoprotein lipase (LPL) enzyme. We analyzed the impact of this mutation on the progression of coronary... Abstract
Cited 27 times since 1996 (0.9 per year) source: EuropePMC
The veterinary quarterly, Volume 18, Issue 3, 1 1 1996, Pages 95-99 Equine arteritis virus: a review of clinical features and management aspects. Glaser AL, de Vries AA, Rottier PJ, Horzinek MC, Colenbrander B
Sero-epidemiological surveys have revealed that equine arteritis virus (EAV) is prevalent in most European countries. The virus causes sporadic cases of respiratory disease and abortion in horses, the incidence of which has increased in recent years. Mares and geldings eliminate virus after acute infection, but 30% to 60% of stallions become persistently infected. In these animals, EAV is maintained within the reproductive tract and is shed continuously in the semen. Persistent infection with EA... Abstract
Cited 3 times since 1996 (0.1 per year) source: EuropePMC
Lung cancer (Amsterdam, Netherlands), Volume 15, Issue 1, 1 1 1996, Pages 131-135 Actinomycosis, a sheep in wolves' clothes. Neijens V, van Heerde P, van der Heijden A, Baas P
We present a patient referred for radiotherapy for a presumed pulmonary malignancy, who was found to suffer from an actinomycotic infection. This case illustrates the importance of early consideration of actinomycosis when diagnostic methods are negative for malignancy or specific chestwall and bony lesions are observed. Abstract
Cited 10 times since 1996 (0.3 per year) source: EuropePMC
European heart journal, Volume 17, Issue 8, 1 1 1996, Pages 1158-1166 Phosphorus magnetic resonance spectroscopy of the human heart: current status and clinical implications. Beyerbacht HP, Vliegen HW, Lamb HJ, Doornbos J, de Roos A, van der Laarse A, van der Wall EE
Cited 26 times since 1996 (0.9 per year) source: EuropePMC
European heart journal, Volume 17, Issue 8, 1 1 1996, Pages 1271-1278 Cardiac anatomy, function and metabolism in elite cyclists assessed by magnetic resonance imaging and spectroscopy. Pluim BM, Chin JC, De Roos A, Doornbos J, Siebelink HM, Van der Laarse A, Vliegen HW, Lamerichs RM, Bruschke AV, Van der Wall EE
We investigated whether left ventricular hypertrophy in elite cyclists is associated with functional changes or abnormal energy metabolism. Left ventricular hypertrophy is a powerful risk factor for sudden cardiac death with different prognostic significance among the various geometric forms. Cyclists may have a combination of mixed eccentric and concentric hypertrophy. Magnetic resonance imaging was used to define left ventricular mass, geometry and function. Thirteen highly trained male cyclis... Abstract
Cited 29 times since 1996 (1 per year) source: EuropePMC
Surgical endoscopy, Volume 10, Issue 7, 1 1 1996, Pages 721-723 Advantages of limited thoracoscopic sympathectomy. Bonjer HJ, Hamming JF, du Bois NAJJ, van Urk H
Background: Thoracoscopic resection of the first through the fourth thoracic sympathetic ganglion for palmary and axillary hyperhidrosis and Raynaud's syndrome is associated with a high initial success rate. However, the reported incidence of compensatory hyperhidrosis of the trunk and legs and Horner's syndrome are high. This study assesses the results of thoracoscopic sympathectomy limited to transection of the interganglionic trunk or resection of one or two thoracic ganglia. Method... Abstract
Cited 3 times since 1996 (0.1 per year) source: EuropePMC
Angiology, Volume 47, Issue 7, 1 1 1996, Pages 633-642 The influence of angiographic endpoints on the outcome of lipid intervention studies. A proposal for standardization. REGRESS study group. Jukema JW, van Boven AJ, Zinderman AH, Bal ET, Reiber JH, Bruschke AV
The aims of this study were to evaluate the influence of different coronary angiographic endpoints on the outcome of lipid intervention studies and to formulate a proposal for angiographic endpoint standardization. In recent angiographic intervention studies a confusing diversity in angiographic endpoints has been used to determine the outcome. In addition, differences in study populations (eg, bypass patients included or not) could influence results. This makes comparisons between studies cumbe... Abstract
Cited 5 times since 1996 (0.2 per year) source: EuropePMC
Catheterization and cardiovascular diagnosis, Volume 38, Issue 2, 1 1 1996, Pages 135-143 Micro stent, quantitative coronary angiography, and procedural results. Tresukosol D, Schalij MJ, Savalle LH, Jukema JW, Buis B, Reiber JH, Bruschke AV
The Micro stent (MS) is a radiopaque stainless steel balloon expandable intracoronary stent. The stent is mounted on a rapid-exchange delivery system. From August 1994-March 1995, 127 MS were implanted in 85 patients (pts, 1.5 stents/pt, 85 in native vessels and 42 in bypass vein grafts, 61 males and 24 female, age 33-77 yr, mean age 61 +/- 10 yr). Pts studied were scheduled for either elective PTCA (n = 62, 73%) or PTCA for acute myocardial infarction (n = 23, 27%). Elective stent implantation... Abstract
Cited 11 times since 1996 (0.4 per year) source: EuropePMC
International journal of cardiac imaging, Volume 12, Issue 2, 1 1 1996, Pages 69-78 Left ventricular regression equations from single plane cine and digital X-ray ventriculograms revisited. Reiber JH, Viddeleer AR, Koning G, Schalij MJ, Lange PE
For the assessment of left ventricular volume from X-ray ventriculograms, widely known regression equations are used to correct for the irregular shape of the left ventricular lumen and the presence of the papillary muscles and trabeculations. These regression equations were derived in the late nineteen sixties and seventies. With all the changes in X-ray technology that have taken place over the past 20-30 years, the question was raised whether these regression equations were still valid. There... Abstract
Cited 2 times since 1996 (0.1 per year) source: EuropePMC
International journal of cardiac imaging, Volume 12, Issue 2, 1 1 1996, Pages 79-83 Imaging of recurrent ventricular septal defect and supravalvular pulmonary stenosis eight years after assumed total surgical repair of tetralogy of Fallot. van Dijkman PR, Voskuil K, Hazekamp MG, van der Wall EE
A 42-year-old man underwent assumed total surgical repair of an acyanotic tetralogy of Fallot: a perimembranous ventricular septal defect (VSD) was closed with a dacron patch and myectomy of the infundibulum of the right ventricular outflow tract was performed. Reexamination eight years later revealed a large recurrent VSD and by surprise a narrow supravalvular ridge above rudimentary pulmonary cusps in the pulmonary trunk, leading to a pressure drop of 70 mmHg across the supravalvular stenosis.... Abstract
Cited 4 times since 1996 (0.1 per year) source: EuropePMC
The American journal of physiology, Volume 270, Issue 6 Pt 2, 1 1 1996, Pages H2149-56 Low external pH limits cell death of energy-depleted cardiomyocytes by attenuation of Ca2+ overload. Atsma DE, Bastiaanse EM, Van der Valk L, Van der Laarse A
We studied the effect of external pH (pHe) on cell injury, ATP content, and intracellular concentration of Ca2+ ([Ca2+]i), Na+ ([Na+]i), and H+ (pHi) during metabolic inhibition (NaCN + 2-deoxyglucose) in neonatal rat cardiomyocytes. Cell death during metabolic inhibition decreased at pHe < 7.4, with almost no cell death at pHe 6.0. Lowering pHe resulted in only temporary ATP conservation. During metabolic inhibition at pHe 7.4, [Ca2+]i rose from 86 +/- 44 nM to 2.5 +/- 0.4 microM, but at pHe... Abstract
Cited 67 times since 1996 (2.3 per year) source: EuropePMC
Virology, Volume 220, Issue 2, 1 1 1996, Pages 367-376 Activation of oriLyt, the lytic origin of DNA replication of Epstein-Barr virus, by BZLF1. Schepers A, Pich D, Hammerschmidt W
oriLyt, the cis-acting element of the lytic origin of DNA replication of Epstein-Barr virus, is activated by the viral transactivator BZLF1 which belongs to the extended bZIP class of transcription factors. Seven binding sites for BZLF1, so-called ZRE sites, are located within oriLyt. By mutational analysis of individual ZRE sites, we found that lytic DNA replication is dependent on only four of these sites which colocate with the promoter of the BHLF1 gene. The remaining three ZRE sites distal... Abstract
Cited 1 times since 1996 (0 per year) source: EuropePMC
Medizinische Klinik (Munich, Germany : 1983), Volume 91, Issue 6, 1 1 1996, Pages 417-419 [Ticlopidine-induced pancytopenia: therapy of agranulocytosis with granulocyte colony stimulating factor]. Schneider AW, Fechler L, Gilfrich HJ
Cited 5 times since 1996 (0.2 per year) source: EuropePMC
European journal of radiology, Volume 22, Issue 2, 1 1 1996, Pages 158-160 Percutaneous drainage of septic glenohumoral arthritis. de Witte MT, van Overhagen H, Hamming JF, Laméris JS
Cited 36 times since 1996 (1.2 per year) source: EuropePMC
Surgical endoscopy, Volume 10, Issue 5, 1 1 1996, Pages 490-494 Laparoscopic surgery in the rat. Beneficial effect on body weight and tumor take. Bouvy ND, Marquet RL, Hamming JF, Jeekel J, Bonjer HJ
Background: The ability of laparoscopic techniques to treat malignant disease is controversial. We developed a rat model to assess metabolic and oncological effects of laparoscopic surgery. Methods: Experiment I. The postoperative body weight in 10 rats having laparoscopic bowel resection (group I), 10 rats having open bowel resection (group II) and 5 rats having anesthesia only (group III) was determined. Experiment II. Tumor take was scored in 11 rats having laparoscopic bowel resection (group... Abstract
Fortschritte der Medizin, Volume 114, Issue 8, 1 1 1996, Pages 91-98 [Reduction of cardiovascular events with pravastatin. A pooled analysis of clinical events within the scope of the Pravastatin Atherosclerosis Intervention Program]. Byington RP, Jukema JW, Salonen JT, Pitt B, Bruschke AV, Hoen H, Furberg CD, Mancini GB
Background: It has been documented that the HMG coenzyme A reductase inhibitors, or statins, can decrease cardiovascular events and mortality in patients with clinical coronary disease and moderately to severely elevated lipid levels. Additional data are required to demonstrate a reduction of vascular events in coronary patients with less than severely elevated lipid levels and in subgroups of this population. Methods and results: Clinical data from four atherosclerosis regression trials that ev... Abstract
Cited 61 times since 1996 (2.1 per year) source: EuropePMC
Diseases of the colon and rectum, Volume 39, Issue 3, 1 1 1996, Pages 323-328 Surgery for local recurrence of rectal carcinoma. Wiggers T, de Vries MR, Veeze-Kuypers B
Purpose: This study was designed to evaluate results, especially mortality and morbidity, of surgical resection with curative intent for patients with a local recurrence of rectal cancer, in combination with radiotherapy. Methods: Consecutive medical records of 163 patients with local recurrence of rectal carcinoma after previous "curative" therapy for primary rectal cancer were reviewed. Although 35 patients had an exploratory laparotomy, only 27 had local recurrence amendable to rese... Abstract
Cited 35 times since 1996 (1.2 per year) source: EuropePMC
Arteriosclerosis, thrombosis, and vascular biology, Volume 16, Issue 3, 1 1 1996, Pages 425-430 Evidence for a synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis in symptomatic patients with normal to moderately raised cholesterol levels. The REGRESS Study Group. Jukema JW, Zwinderman AH, van Boven AJ, Reiber JH, Van der Laarse A, Lie KI, Bruschke AV
To date, lipid-lowering therapy appears to be the most effective medical intervention to retard progression of coronary atherosclerosis. In spite of promising experimental results, clinical trials completed so far have failed to demonstrate that calcium channel blockers (CCBs) alone influence the evolution of established coronary atherosclerosis. To assess whether the two therapies may have an additive or synergistic beneficial effect on human atherosclerosis, we reviewed in this regard the data... Abstract
Cited 2 times since 1996 (0.1 per year) source: EuropePMC
The Annals of thoracic surgery, Volume 61, Issue 3, 1 1 1996, Pages 1005-1006 Pulmonary autograft in ventricular septal defect-aortic insufficiency complex. Schoof PH, Hazekamp MG, Huysmans HA
Pulmonary autograft aortic root replacement in a child with the ventricular septal defect-aortic insufficiency complex is described. It offers all the advantages of the autograft, avoids closure of the ventricular septal defect, and prevents the use of prosthetic material. Abstract